Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cheng-Liang Chi, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Lee JJ, Memar Montazerin S, Shojaei F, Chi G. Current Opinion on the use of Direct Oral Anticoagulants for the Prophylaxis of Venous Thromboembolism among Medical Inpatients. Ther Clin Risk Manag. 2021; 17:471-487. PMID: 34079269.
    Citations:    
  2. Jafarizade M, Kahe F, Sharfaei S, Momenzadeh K, Pitliya A, Zahedi Tajrishi F, Singh P, Chi G. The Role of Interleukin-27 in Atherosclerosis: A Contemporary Review. Cardiology. 2021; 146(4):517-530. PMID: 34010834.
    Citations:    Fields:    Translation:Humans
  3. Memar Montazerin S, Najafi H, Shojaei F, Chi G, Goudarzi S, Sharfaei S, Kahe F, Hassanzadeh S. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications. Infez Med. 2021 Mar 01; 29(1):1-9. PMID: 33664168.
    Citations: 6     Fields:    Translation:HumansCells
  4. Jamil A, Jamil U, Singh K, Khan F, Chi G. Extended Thromboprophylaxis With Betrixaban or Rivaroxaban for Acutely Ill Hospitalized Medical Patients: Meta-Analysis of Prespecified Subgroups. Crit Pathw Cardiol. 2021 03 01; 20(1):16-24. PMID: 32657973.
    Citations: 2     Fields:    Translation:Humans
  5. Lee JJ, Montazerin SM, Jamil A, Jamil U, Marszalek J, Chuang ML, Chi G. Association between red blood cell distribution width and mortality and severity among patients with COVID-19: A systematic review and meta-analysis. J Med Virol. 2021 04; 93(4):2513-2522. PMID: 33448439.
    Citations: 10     Fields:    Translation:HumansCells
  6. Shojaei F, Habibi Z, Goudarzi S, Firouzabadi FD, Montazerin SM, Najafi H, Kahe F, Momenzadeh K, Mir M, Khan F, Jamil U, Jamil A, Lee JJ, Chi G. COVID-19: A double threat to takotsubo cardiomyopathy and spontaneous coronary artery dissection? Med Hypotheses. 2021 Jan; 146:110410. PMID: 33267999.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  7. Habibi S, Ghaffarpasand E, Shojaei F, Alihashemi M, Kahe F, Zahedi Tajrishi F, Chi G. Prognostic Value of Biomarkers in Cardiac Allograft Vasculopathy following Heart Transplantation: A Literature Review. Cardiology. 2020; 145(11):693-702. PMID: 32892195.
    Citations:    Fields:    Translation:Humans
  8. Goudarzi S, Memar Montazerin S, Najafi H, Shojaei F, Chi G. Effect of Vitamins and Dietary Supplements on Cardiovascular Health. Crit Pathw Cardiol. 2020 09; 19(3):153-159. PMID: 32053519.
    Citations: 1     Fields:    Translation:Humans
  9. Chi G, Lee JJ, Jamil A, Gunnam V, Najafi H, Memar Montazerin S, Shojaei F, Marszalek J. Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis. J Clin Med. 2020 Aug 03; 9(8). PMID: 32756383.
    Citations: 35     
  10. Chi G, Marszalek J. Differential effect of ticagrelor on irreversible harms in diabetes. Lancet. 2020 07 11; 396(10244):93. PMID: 32653064.
    Citations:    Fields:    Translation:Humans
  11. Chi G, Cushman M. Attention and citation: Common interests of researchers and journals. Res Pract Thromb Haemost. 2020 Mar; 4(3):353-356. PMID: 32211569.
    Citations: 1     
  12. Kahe F, Sharfaei S, Pitliya A, Jafarizade M, Seifirad S, Habibi S, Chi G. Coronary artery tortuosity: a narrative review. Coron Artery Dis. 2020 03; 31(2):187-192. PMID: 31211725.
    Citations: 5     Fields:    Translation:Humans
  13. Nafee T, Gibson CM, Travis R, Yee MK, Kerneis M, Chi G, AlKhalfan F, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Goldhaber SZ. Machine learning to predict venous thrombosis in acutely ill medical patients. Res Pract Thromb Haemost. 2020 Feb; 4(2):230-237. PMID: 32110753.
    Citations: 7     
  14. Kazmi SHA, Datta S, Chi G, Nafee T, Yee M, Kalia A, Sharfaei S, Shojaei F, Mirwais S, Gibson CM. The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives. Med Devices (Auckl). 2020; 13:1-12. PMID: 32021496.
    Citations:    
  15. Jamil A, Tajrishi FZ, Kahe F, Najafi H, Montazerin SM, Shojaei F, Chitsazan M, Chitsazan M, Liu Y, Chi G. Spontaneous coronary artery dissection managed with a conservative or revascularization approach: a meta-analysis. J Cardiovasc Med (Hagerstown). 2020 01; 21(1):42-50. PMID: 31688430.
    Citations: 1     Fields:    Translation:Humans
  16. Alkhalfan F, Nafee T, Yee MK, Chi G, Kalayci A, Plotnikov A, Braunwald E, Gibson CM. Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial). Am J Cardiol. 2020 03 01; 125(5):661-669. PMID: 31898965.
    Citations:    Fields:    Translation:Humans
  17. Tajrishi FZ, Chitsazan M, Chitsazan M, Shojaei F, Gunnam V, Chi G. Smartwatch for the Detection of Atrial Fibrillation. Crit Pathw Cardiol. 2019 12; 18(4):176-184. PMID: 31725508.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  18. Kandzari DE, Lembo NJ, Carlson HD, Kalynych A, Spertus JA, Gibson CM, Chi G, Morgan J, Rinehart S, Yehya A, Qian Z, Ajose B, Karmpaliotis D. Procedural, clinical, and health status outcomes in chronic total coronary occlusion revascularization: Results from the PERSPECTIVE study. Catheter Cardiovasc Interv. 2020 09 01; 96(3):567-576. PMID: 31512377.
    Citations:    Fields:    Translation:Humans
  19. Tajrishi FZ, Ahmad A, Jamil A, Sharfaei S, Goudarzi S, Homayounieh F, Pitliya A, Kahe F, Chi G. Spontaneous coronary artery dissection and associated myocardial bridging: Current evidence from cohort study and case reports. Med Hypotheses. 2019 Jul; 128:50-53. PMID: 31203908.
    Citations: 6     Fields:    Translation:Humans
  20. Duran JM, Naderi S, Vidula M, Michalak N, Chi G, Lindsay M, Ghoshhajra B, Gibson CM, Wood MJ. Spontaneous coronary artery dissection and its association with takotsubo syndrome: Novel insights from a tertiary center registry. Catheter Cardiovasc Interv. 2020 02 15; 95(3):485-491. PMID: 31037831.
    Citations: 7     Fields:    Translation:Humans
  21. Yee MK, Gibson CM, Nafee T, Kerneis M, Daaboul Y, Korjian S, Chi G, AlKhalfan F, Hernandez AF, Hull RD, Cohen AT, Goldhaber SZ. Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial. TH Open. 2019 Apr; 3(2):e103-e108. PMID: 31249989.
    Citations: 1     
  22. Chi G, Cushman M. Social media optimization in medicine: A journal's perspective. Res Pract Thromb Haemost. 2019 Apr; 3(2):144-146. PMID: 31011694.
    Citations: 5     
  23. Sharma S, Kaadan MI, Duran JM, Ponzini F, Mishra S, Tsiaras SV, Scott NS, Weinberg I, Ghoshhajra B, Lindsay M, Gibson CM, Chi G, Michalak N, Wood MJ. Risk Factors, Imaging Findings, and Sex Differences in Spontaneous Coronary Artery Dissection. Am J Cardiol. 2019 06 01; 123(11):1783-1787. PMID: 30929769.
    Citations: 10     Fields:    Translation:Humans
  24. Nafee T, Gibson CM, Yee MK, Kerneis M, Daaboul Y, Korjian S, Chi G, Kalayci A, Afzal MK, Kazmi H, Datta S, AlKhalfan F, Hernandez AF, Hull RD, Harrington RA, Cohen AT, Goldhaber SZ. Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients. Circulation. 2019 02 26; 139(9):1234-1236. PMID: 30802169.
    Citations: 3     Fields:    Translation:Humans
  25. Chi G, Gibson CM, Kalayci A, Cohen AT, Hernandez AF, Hull RD, Kahe F, Jafarizade M, Sharfaei S, Liu Y, Harrington RA, Goldhaber SZ. Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy. Intensive Care Med. 2019 04; 45(4):477-487. PMID: 30778649.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  26. Chi G, Sharfaei S, Jafarizade M, Kahe F, Liu Y. Extended or shorter prophylaxis for venous thromboembolism in acutely ill hospitalized patients: Updated meta-analysis of randomized trials. Vasc Med. 2019 Apr; 24(2):156-158. PMID: 30755140.
    Citations: 4     Fields:    Translation:Humans
  27. Elfert KA, Abdelwahed M, Chi G. Chikungunya Virus Infection-related Rhabdomyolysis: A Case Report. Cureus. 2019 Feb 08; 11(2):e4036. PMID: 31011498.
    Citations:    
  28. Kalayci A, Gibson CM, Chi G, Yee MK, Korjian S, Datta S, Nafee T, Gurin M, Haroian N, Qamar I, Hull RD, Hernandez AF, Cohen AT, Harrington RA, Goldhaber SZ. Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial. Thromb Haemost. 2018 Dec; 118(12):2046-2052. PMID: 30419597.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  29. Chi G, Gibson CM, Liu Y, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Goldhaber SZ. Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial. Am J Hematol. 2019 01; 94(1):21-28. PMID: 30252149.
    Citations: 13     Fields:    Translation:Humans
  30. Nafee T, Gibson CM, Yee MK, Alkhalfan F, Chi G, Travis R, Mir M, Kalayci A, Jafarizade M, Ganti A, Kazmi SH, Ghaffarpasand E, Pitliya A, Datta S, Sharfaei S, Alihashemi M, Elsaiey A, Qamar I, Jahansouz M, Talib U, Kahe F, Habibi S, Abdelwahed M, Tariq F, Kaur M, Younes A, Walia SS, Singh A, Dildar SM, Afzal MK, Kerneis M. Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism. Expert Rev Cardiovasc Ther. 2018 Nov; 16(11):845-855. PMID: 30296387.
    Citations: 1     Fields:    Translation:Humans
  31. Chi G, Yee MK, Kalayci A, Kerneis M, AlKhalfan F, Mehran R, Bode C, Halperin JL, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Peterson ED, Fox KAA, Gibson CM. Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention. J Thromb Thrombolysis. 2018 Oct; 46(3):346-350. PMID: 29943350.
    Citations: 5     Fields:    Translation:Humans
  32. Ghaffarpasand E, Tehrani MD, Marszalek J, Chi G. Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis. J Thromb Thrombolysis. 2018 Oct; 46(3):332-338. PMID: 29876713.
    Citations: 4     Fields:    Translation:Humans
  33. Pitliya A, Datta S, Kalayci A, Kahe F, Sharfaei S, Jafarizade M, Goudarzi S, Chi G. Eosinophilic inflammation in spontaneous coronary artery dissection: A potential therapeutic target? Med Hypotheses. 2018 Dec; 121:91-94. PMID: 30396503.
    Citations: 4     Fields:    Translation:HumansCells
  34. AlKhalfan F, Kerneis M, Nafee T, Yee MK, Chi G, Plotnikov A, Braunwald E, Gibson CM. D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy). Am J Cardiol. 2018 11 01; 122(9):1459-1464. PMID: 30217378.
    Citations: 4     Fields:    Translation:Humans
  35. Chi G, Kerneis M, Kalayci A, Liu Y, Mehran R, Bode C, Halperin JL, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Peterson ED, Fox KAA, Gibson CM. Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial. Am Heart J. 2018 09; 203:17-24. PMID: 30015064.
    Citations: 5     Fields:    Translation:Humans
  36. Norouzi A, Chi G, Shafaee Fard S, Sezavar M, Sarkarat F, Rakhshan V, Kahe F. Scleral exposure alterations following Le Fort I osteotomy (with and without maxillary impaction) in skeletal class III patients: A before-and-after clinical trial. J Craniomaxillofac Surg. 2018 Sep; 46(9):1480-1483. PMID: 30055891.
    Citations:    Fields:    Translation:Humans
  37. Chi G, Gibson CM, Hernandez AF, Hull RD, Kazmi SHA, Younes A, Walia SS, Pitliya A, Singh A, Kahe F, Kalayci A, Nafee T, Kerneis M, AlKhalfan F, Cohen AT, Harrington RA, Goldhaber SZ. Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy. Am J Med. 2018 08; 131(8):972.e1-972.e7. PMID: 29660351.
    Citations: 4     Fields:    Translation:Humans
  38. Chi G, Jamil A, Jamil U, Balouch MA, Marszalek J, Kahe F, Habibi S, Radulovic M. Effect of intensive versus standard blood pressure control on major adverse cardiac events and serious adverse events: A bivariate analysis of randomized controlled trials. Clin Exp Hypertens. 2018 Apr 10; 1-8. PMID: 29634378.
    Citations: 5     Fields:    
  39. Kerneis M, Gibson CM, Chi G, Mehran R, AlKhalfan F, Talib U, Pahlavani S, Mir M, Bode C, Halperin JL, Nafee T, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Fox KAA, Cohen M. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. JACC Cardiovasc Interv. 2018 04 09; 11(7):626-634. PMID: 29550085.
    Citations: 7     Fields:    Translation:Humans
  40. Chi G, Jamil A, Radulovic M, Jamil U, Balouch MA, Marszalek J, Karimi Z, Pahlavani S, Jafarizade M, Shaukat H, Kumar S, Kalayci A. Dual antithrombotic plus adjunctive antiinflammatory therapy to improve cardiovascular outcome in atrial fibrillation patients with concurrent acute coronary syndrome: A triple-pathway strategy. Med Hypotheses. 2018 May; 114:40-44. PMID: 29602462.
    Citations: 1     Fields:    Translation:Humans
  41. Gibson CM, Jennings LK, Chi G, Yee MK, Halaby R, Nafee T, AlKhalfan F, Kerneis M, Korjian S, Daaboul Y, Goldhaber SZ, Hull RD, Hernandez AF, Cohen AT, Harrington RA. Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial. TH Open. 2018 Jan; 2(1):e16-e24. PMID: 31249924.
    Citations: 2     
  42. Chi G, Yee MK, Amin AN, Goldhaber SZ, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Gibson CM. Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial). Circulation. 2018 01 02; 137(1):91-94. PMID: 29279341.
    Citations: 10     Fields:    Translation:Humans
  43. Karimi Z, Kahe F, Jamil A, Marszalek J, Ghanbari A, Afarideh M, Khajeh E, Noshad S, Esteghamati A, Chi G. Intercellular adhesion molecule-1 in diabetic patients with and without microalbuminuria. Diabetes Metab Syndr. 2018 May; 12(3):365-368. PMID: 29310968.
    Citations: 11     Fields:    Translation:Humans
  44. Gibson CM, Nafee T, Yee MK, Chi G, Korjian S, Daaboul Y, AlKhalfan F, Kerneis M, Goldhaber SZ, Hull R, Hernandez AF, Cohen AT, Harrington RA. Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients. Am Heart J. 2018 04; 198:84-90. PMID: 29653652.
    Citations: 7     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  45. Raza I, Raza A, Razaa SA, Sadar AB, Qureshi AU, Talib U, Chi G. Surface Microbiology of Smartphone Screen Protectors Among Healthcare Professionals. Cureus. 2017 Dec 26; 9(12):e1989. PMID: 29503783.
    Citations: 5     
  46. Chi G, Marszalek J. Letter by Chi and Marszalek Regarding Article, "Composite End Points in Clinical Research: A Time for Reappraisal". Circulation. 2017 12 12; 136(24):2397-2398. PMID: 29229626.
    Citations:    Fields:    
  47. Chi G, Goldhaber SZ, Hull RD, Hernandez AF, Kerneis M, Al Khalfan F, Cohen AT, Harrington RA, Gibson CM. Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial. Thromb Haemost. 2017 12; 117(12):2389-2395. PMID: 29212126.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  48. Chi G, Januzzi JL, Korjian S, Daaboul Y, Goldhaber SZ, Hernandez AF, Hull RD, Gold A, Cohen AT, Harrington RA, Gibson CM. N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy. J Thromb Thrombolysis. 2017 Nov; 44(4):457-465. PMID: 28905172.
    Citations: 4     Fields:    Translation:Humans
  49. Chi G, Goldhaber SZ, Kittelson JM, Turpie AGG, Hernandez AF, Hull RD, Gold A, Curnutte JT, Cohen AT, Harrington RA, Gibson CM. Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis. J Thromb Haemost. 2017 10; 15(10):1913-1922. PMID: 28762617.
    Citations: 8     Fields:    Translation:Humans
  50. Gibson CM, Korjian S, Chi G, Daaboul Y, Jain P, Arbetter D, Goldhaber SZ, Hull R, Hernandez AF, Lopes RD, Gold A, Cohen AT, Harrington RA. Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy. J Am Heart Assoc. 2017 Jul 11; 6(7). PMID: 28698258.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  51. Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G. The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification. TH Open. 2017 Jun; 1(1):e56-e65. PMID: 31249911.
    Citations: 26     
  52. Marszalek J, Mehrsefat S, Chi G. The risk of stroke among acutely ill hospitalized medical patients: lessons from recent trials on extended-duration thromboprophylaxis. Expert Rev Hematol. 2017 08; 10(8):679-684. PMID: 28617144.
    Citations: 1     Fields:    Translation:Humans
  53. Gibson CM, Goldhaber SZ, Cohen AT, Nafee T, Hernandez AF, Hull R, Korjian S, Daaboul Y, Chi G, Yee M, Harrington RA. When academic research organizations and clinical research organizations disagree: Processes to minimize discrepancies prior to unblinding of randomized trials. Am Heart J. 2017 07; 189:1-8. PMID: 28625365.
    Citations: 2     Fields:    Translation:Humans
  54. Nafee T, Aslam A, Chi G, Pahlavani S, Nimri D, Kuchkuntla AR, Talib U, Michalak N, Daaboul Y, Korjian S, Gallo A, Gibson CM. Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors. Expert Rev Cardiovasc Ther. 2017 Apr; 15(4):237-245. PMID: 28282497.
    Citations: 3     Fields:    Translation:Humans
  55. Gibson CM, Chi G, Halaby R, Korjian S, Daaboul Y, Jain P, Arbetter D, Goldhaber SZ, Hull R, Hernandez AF, Gold A, Bandman O, Harrington RA, Cohen AT. Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban). Circulation. 2017 02 14; 135(7):648-655. PMID: 27881569.
    Citations: 23     Fields:    Translation:Humans
  56. Gibson CM, Pinto DS, Chi G, Arbetter D, Yee M, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Burton P, van Eickels M, Korjian S, Daaboul Y, Jain P, Lip GY, Cohen M, Peterson ED, Fox KA. Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy. Circulation. 2017 Jan 24; 135(4):323-333. PMID: 27881555.
    Citations: 28     Fields:    Translation:Humans
  57. Daaboul Y, Korjian S, Weaver WD, Kloner RA, Giugliano RP, Carr J, Neal BJ, Chi G, Cochet M, Goodell L, Michalak N, Rusowicz-Orazem L, Alkathery T, Allaham H, Routray S, Szlosek D, Jain P, Gibson CM. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial). Am J Cardiol. 2016 09 01; 118(5):625-31. PMID: 27392509.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  58. Popma CJ, Sheng S, Korjian S, Daaboul Y, Chi G, Tricoci P, Huang Z, Moliterno DJ, White HD, Van de Werf F, Harrington RA, Wallentin L, Held C, Armstrong PW, Aylward PE, Strony J, Mahaffey KW, Gibson CM. Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy. Circ Cardiovasc Interv. 2016 May; 9(5):e003114. PMID: 27162212.
    Citations: 2     Fields:    Translation:HumansAnimals
  59. Halaby R, Popma CJ, Cohen A, Chi G, Zacarkim MR, Romero G, Goldhaber SZ, Hull R, Hernandez A, Mentz R, Harrington R, Lip G, Peacock F, Welker J, Martin-Loeches I, Daaboul Y, Korjian S, Gibson CM. D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis. 2015 Jan; 39(1):55-9. PMID: 25006010.
    Citations: 21     Fields:    Translation:Humans
  60. Chi GC, Hsu FS, Yang CC, Wei JC. Scleroderma and failed response to alefacept. Rheumatology (Oxford). 2005 Oct; 44(10):1328-30. PMID: 15972344.
    Citations: 1     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Chi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (197)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.